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caesarean section under spinal anaesthesia.
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Abstract

Background: Spinal anaesthesia is the standard of care for elective caesarean delivery. It has advantages over general anaesthesia. However the sympathetic blockade induced by spinal anaesthesia results in an 80 percent incidence of hypotension without
prophylactic management. Current evidence supports co-loading with intravenous fluids in conjunction with the use of vasopressors as the most effective way to prevent and treat the hypotension. Phenylephrine is the accepted vasopressor of choice in
the parturient. A prophylactic phenylephrine infusion combined with a fluid co-load is proven to be an effective and safe method
of maintaining maternal hemodynamic stability. While most published studies have assessed the effectiveness of a prophylactic
phenylephrine fixed dose infusion, few studies have assessed the effect of a prophylactic phenylephrine weight adjusted dose
infusion on maintaining maternal hemodynamic stability following spinal anesthesia for a cesarean delivery.
Objective: To compare the incidence of hypotension between women undergoing elective caesarean section under spinal anaesthesia, receiving prophylactic phenylephrine infusion at a fixed dose of 37.5 micrograms per minute versus a weight adjusted
dose of 0.5 micrograms per kilogram per minute.
Methods: One hundred and eight patients scheduled for non-urgent caesarean section under spinal anaesthesia were randomized into 2 groups; control group and intervention group using a computer generated table of numbers.
Control group; Received prophylactic phenylephrine fixed dose infusion at 37.5 micrograms per minute.
Intervention group; Received prophylactic phenylephrine weight adjusted dose infusion at 0.5 micrograms per kilogram per
minute
Results: The two groups had similar baseline characteristics in terms of ; Age, sex, weight and height. There was a 35.2% incidence of hypotension in the fixed dose group and an 18.6% incidence of hypotension in the weight adjusted dose group. This
difference was found to be of borderline statistical significance p-value 0.05, and the difference in the incidence rates between
the two groups was found to be statistically significant p= 0.03. The difference in the incidence of reactive hypertension and
bradycardia between the two groups was not statistically significant: p-value of 0.19 for reactive hypertension and p-value of
0.42 for the incidence of bradycardia. There was also no statistically significant difference in the use of phenylephrine boluses,
use of atropine, intravenous fluid used and the number of times the infusion was stopped.
Conclusion: Among this population, the incidence of hypotension was significantly less in the weight adjusted dose group than
in the fixed dose group. There was no difference in the number of physician interventions required to keep the blood pressure
within 20% of baseline, and no difference in the proportion of reactive hypertension or bradycardia between the two groups.
Administering prophylactic phenylephrine infusion at a weight adjusted dose of 0.5 micrograms per kilogram per minute results
in a lower incidence of hypotension compared to its administration at a fixed dose of 37.5 micrograms per minute.
Keywords: Weight adjusted dose, fixed dose prophylactic phenylephrine infusion, systolic blood pressure, caesarean section,
spinal anaesthesia.
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Introduction
Spinal anaesthesia is the preferred mode of anaesthesia
for elective caesarean delivery1,2. Benefits include avoiding the risks involved during general anaesthesia such as
difficult intubation and aspiration of gastric contents3,4.
Its use has been associated with reduced maternal mortality and better neonatal outcomes4.
African Health Sciences Vol 16 Issue 2, June 2016

Hypotension is the most common complication of spinal anaesthesia5,6. It may be defined in terms of a systolic
blood pressure of less than 90 or 100mmHg or in relative terms as a 20% decline of the systolic blood pressure
from baseline7.
Consequences of untreated severe hypotension in the
mother include: nausea and vomiting, cardiovascular collapse, unconsciousness with resulting pulmonary aspiration, and in extreme cases cardio respiratory arrest and to
the baby: impaired placental perfusion leading to hypoxia,
foetal acidosis and neurological injury8,9.

sion would be, in terms of maintaining maternal systolic blood pressure within 20% of the baseline following
spinal anaesthesia for caesarean section. Most drugs in
anaesthesia as well as in medical practice, including vasopressors such as phenylephrine are administered at a
weight adjusted dose as per medical guidelines/recommendations: thus supporting this study’s investigation of
a weight adjusted dose infusion.

This study was designed to assess how effective phenylephrine weight adjusted dose infusion regimen would be
compared to a fixed dose infusion in maintaining materMeasures taken to decrease the risk of hypotension in- nal systolic blood pressure within 20% of baseline folclude intravenous administration of fluids either crystal- lowing spinal anaesthesia given for caesarean section.
loids or colloids5,10,11,12,13, prevention of aortocaval com- Our study question was: does use of prophylactic phenpression by placing a wedge of 12cm beneath the right ylephrine weight adjusted dose infusion result in a lower
buttock and use of vasopressors5,7,8,14.
incidence of hypotension following spinal anaesthesia
Ephedrine is an alpha and beta receptor agonist with given for caesarean delivery compared to its use as a proboth direct and indirect mechanism of action, but with a phylactic fixed dose infusion?
slow onset of action, making it difficult to titrate and use
with an appropriate bolus dose14.
We hypothesised that a weight adjusted dose of prophyStudies done have showed that ephedrine crosses the pla- lactic phenylephrine infusion results in a lower incidence
centa and causes possible alterations in foetal physiology. of hypotension compared to a fixed dose infusion folIt is also associated with a higher incidence of nausea and lowing spinal anaesthesia given for caesarean delivery.
vomiting compared to phenylephrine4,15.
Our primary objective was to compare the incidence of
hypotension between the two study groups. Our secondPhenylephrine is a short acting alpha agonist, it is a po- ary objectives were to compare the incidence of reactive
tent vasoconstrictor that counteracts the vasodilatation hypertension and bradycardia between the two groups
due to neuraxial anaesthesia and causes an increase in and establish the number of physician interventions beboth systolic and diastolic blood pressures back to the tween the two study groups.
baseline values7. It is widely used as studies done have
showed better foetal acid base status with reduced inci- Methods
dence of foetal acidosis as well as lower episodes of ma- The study was performed following approval from the
ternal hypotension with the use of prophylactic phenyl- ethical and scientific review committee at the Aga Khan
ephrine regimens14,16. Various studies have found reduced University Hospital, Nairobi. This was a prospective douincidence of hypotension and intra-operative nausea and ble blinded randomized controlled trial; the patient and
vomiting when phenylephrine is administered as a pro- physician administering anaesthesia and collecting data
phylactic infusion at various doses compared with bolus were blinded on the nature of the intervention made.
administration and other methods, however no infusion
regimen studied has been found to be more effective than Since Nairobi is a cosmopolitan city, the patients served
others17,18.
by this hospital cut across most racial groups present
within the country. Patients were recruited from the outHence, the best phenylephrine dose and mode of admin- patient pre-anaesthesia clinics and the maternity ward.
istration remains undetermined. Previously, studies have The target population included all patients admitted for
investigated its use as a prophylactic fixed dose infusion. non-urgent caesarean section at the Aga Khan University
There are no studies that have been done investigating Hospital, Nairobi. The sample population included 108
how effective a prophylactic weight adjusted dose infu- ASA I and II patients going to theatre for non-urgent
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caesarean section between October 2013 to January 2014.
This comprised all eligible patients scheduled for nonurgent caesarean delivery who had given consent for the
study.
All ASA I and II patients over 18 years scheduled for
non-urgent caesarean delivery were included in this study.
Reasons for exclusion from the study were:
1. Patient refusal to participate in the study
2. Patients with contraindications to neuraxial anaesthesia
a. Puncture site infection
b. Hypovolemic shock
c. Coagulopathy
d. Sepsis
e. Features of raised intracranial pressure
3. Patient involved in any other clinical studies
4. Women scheduled for emergency caesarean section
5. Type 1 Diabetes Mellitus
6. Hypertension
7. Severe cardiac disease graded as New York Heart Association Class (NYHA) III-IV
A sample size of 104 patients was sufficient to demonstrate a 17% difference in the proportion of hypotension
between the two groups at 95% confidence level and a
power of 80%.
A study done by Allen et al showed the proportion of
hypotension when a fixed dose of phenylephrine was
used at 25µg/min was 30% and 15% when a dose of
50µg/min was used.17 By using phenylephrine at a dose
of 37.5µg/min we anticipated an incidence of 20%. Our
case series using prophylactic phenylephrine at a weight
adjusted dose of 0.5µg/kg/min resulted in a much reduced incidence of hypotension at 3%.
We therefore hypothesized that there would be a 17%
less incidence of hypotension in the weight adjusted dose
group as compared with the fixed dose infusion. Using
this information and assuming a 5% significance level and
a power of 80%, the required sample size was 52 patients
in each group and a total of 104 patients. We recruited
108 patients to cater for any data entered wrongly, but all
data was clearly entered so we analysed all patients.
Patients were recruited after having signed an informed
consent, which clearly stated that it was a study being
conducted and that their information would be kept con-
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fidential and may be published. Participant flow diagram
is shown in figure 1.
No serious adverse event occurred to any patient for the
entire duration of the study. The patients were free to
withdraw from the study at any stage and still be accorded
standard care.
Simple randomization was done using a computer program; the principal investigator generated a random sequence of numbers. Each of the random numbers was
sequentially assigned to either;
Group 1; prophylactic phenylephrine fixed dose infusion
at 37.5 µg /min
Group 2; prophylactic phenylephrine weight adjusted
dose infusion at 0.5 µg /kg/min.
The study drug was prepared by a physician not involved
in any other aspect of the study in identical 20mls syringes labelled study drug. This physician held the code for
randomization and group allocation. The drug was presented to the anaesthesiologist and the infusion rate was
set at 20 mls per hour for both groups. The presentation
was similar and the only difference was the concentration
of the drug in the syringe. The anaesthesiologist was also
presented with a second 20mls syringe of phenylephrine
50µg/ml for bolus phenylephrine administration in case
systolic blood pressure fell below 20% of baseline.
On arrival to the operating theatres, standard monitoring
was applied with automated non-invasive blood pressure
measurement, electrocardiography and pulse-oximetry:
with the objective of obtaining the baseline cardiovascular parameters. Baseline systolic blood pressure was obtained by taking three readings and calculating an average
of the three readings.
After a local infiltration of 2mls 2% Lidocaine solution,
a midline puncture with a 25 French gauge pencil point
needle was performed at L3/L4 or L4/ L5 interspace,
with the patient in the sitting or lateral decubitus position. After obtaining free flow of CSF, 2mls of bupivacaine and 10µg fentanyl were administered. Patients were
then turned supine with a 15 degree left lateral tilt and
the study drug together with the fluid co-load at 10mls/
kg were administered over 10 minutes. The study drug
was run in an infusion pump at 20mls per hour as the
concentration inside had already been predetermined and
prepared. The sensory block level to both light touch and
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temperature was checked and a modified Bromage motor score recorded. Surgery was allowed to commence as
soon as the sensory block had reached the desired level.
NIBP was measured every 2 minutes till delivery of the
baby.

Analysis was performed using STATA version 12 special edition. Descriptive statistics were used to compare
patients’ characteristics in terms of age, height, weight,
baseline blood pressure and heart rates. Students’ T test
was used to compare if the 2 sample sizes are statistically different. The Chi test was used to compare the proHypotension defined as a reduction in systolic blood portions of hypotension between the two groups. The
pressure of more than 20% from baseline determined students’ T test was used to compare the differences bejust before the administration of regional anaesthesia was tween blood pressure and heart rates reduction between
treated with IV phenylephrine boluses of 50µg. Reactive the two groups.
hypertension defined as a rise of systolic blood pressure
above 20% of baseline was treated by stopping the infu- Observations (participants) were censored at the first
sion, and restarting it if blood pressure fell back to base- event of interest i.e. hypotension or at the end of the obline. Bradycardia defined as heart rate less than 60bpm servation period (end of surgery). Survival time analysis
was treated by stopping the infusion if accompanied by (Kaplan Meir) was used to analyse the time to hypotenreactive hypertension or with IV atropine 0.6mg if ac- sion. Log rank test was used to compare the rate of hypocompanied by hypotension. The presence of intraop- tension in the 2 groups.
erative nausea and vomiting was also noted and treated
appropriately; Rescue antiemetic drugs (either IV ondan- The incidence rates (IR), and the incidence rate ratio
setron 4mg or granisetron 1mg) were to be administered (IRR) were reported alongside their corresponding 95%
at the discretion of the anaesthesiologist. All the com- CI. Kaplan-Meier survival curves were plotted. The test
plications that occurred were noted and recorded by the for differences in the survival distributions was conductanaesthesiologist.
ed using log rank test.
The study drug infusion was discontinued after the delivery of the baby. APGAR score was recorded and othermanagement thereafter was at the discretion of the anaesthesiologist.
Intraoperative data was collected by the anaesthesiologist administering anaesthesia or research assistant both
blinded to patients’ group allocation using the data collection form. Upon collection, data was entered into the
statistical software (SPSS version 15) on the same day in a
coded form and saved, awaiting analysis. All data entered
was verified by the principal investigator. There was no
missing data and no patient required conversion to general anaesthesia.
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The differences between the two groups in the total fluids
given, total phenylephrine boluses and atropine used was
compared using Mann-Whitney non parametric statistical
test. All data was presented as mean +/- standard deviation unless otherwise specified. P≤ 0.05 was considered
statistically significant.
Results
One hundred and eight ASA 1 parturients scheduled to
undergo non- urgent caesarean section were included in
this study. Their baseline characteristics are shown in table 1.
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Table 1: Patients’ baseline characteristics
Fixed dose group
n=54
Mean SD
32.8 4.8

Age in
years
Weight(kg) 79.2 11.7

Height(cm) 162.5 1.01

Weight adjusted dose group P-Value
n=54
Mean SD
33.5 3.6
0.4
82.9 10.3

0.09

162.1 1.09

0.2

Data are mean + SD, T-test used to analyse normal distributed variables
and Mann-Whitney U test for skewed data.
Table 2 shows the sensory block achieved before the start of surgery for the two study groups.

Table 2: sensory block level before start of surgery
Sensory level
T4

Fixed dose group Weight adjusted dose group
n%
n%
11%
20%

T6

79%

66%

T8

10%

14%

Table 3 shows the primary outcome as the proportion of

hypotension in the two groups.

Table 3: Proportion of hypotension between the two groups
HYPOTENSION
No(n%)
Yes (n%)
35 (64.8%)

19(35.2%) 54 (100%)

Intervention weight adjusted dose infusion 44 (81.4%)

10(18.6%) 54 (100%)

Control fixed dose infusion

79 (73.2%)

TOTAL
P- Value
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Total(n%)

29(26.8%) 108 (100%)

0.051
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Table 4 shows the incidence rate of hypotension during

the period of study for the two study groups.

Table 4: Incidence rate of hypotension between the two groups

Fixed dose group
Weight adjusted
dose group
Total
Rate Ratio
Hazard Ratio
P-value

Person time
minutes

Hypotensive
( )
patients n

95% confidence
intervals

19

Rate
per 100 person
minutes
3

636
764

10

1.3

0.7 – 2.4

1400

29

2.1

1.4 – 3

1.9 – 4.7

2.3

0.43
0.035

The results on presence of bradycardia, reactive hyper- the control (fixed dose group) and the intervention
tension and number of physician interventions between (weight adjusted group) are shown in tables 5, 6 and 7
respectively.

Table 5: Difference in the rates of reactive hypertension between the fixed dose group and
the weight adjusted dose group.
Group
Fixed dose group
Weight adjusted dose
group
P=0.19

Proportion
N%
18 34%
11 22%

Person
time
636
730

Rate

95% Confidence Interval

1.6
0.9

0.8- 2.9
0.4 -1.9

Table 6: Test for difference in the proportion of bradycardia between the control and the
intervention arms.
Group
Fixed dose group
Weight adjusted dose
group
P=0.349

Proportion
41.5%
34.0%

Incidence Rate
4.2
3.1

95% Confidence Interval
2.7- 6.2
1.9 – 4.8

Table 7: Physician interventions.
Control: Fixed dose
Percentage/Mean
Infusion
8 15%
African
Healthstopped
Sciences Vol 16 Issue
2, June 2016
Phenylephrine bolus
17 31%
Atropine given
7 13%

Intervention: weight adjusted dose
Percentage/Mean
5 9%
10 19%
6 11%

P- Value
0.374
0.119
0.73
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P=0.349
Table 7: Physician interventions.
Control: Fixed dose
Percentage/Mean
Infusion stopped
8 (15%)
Phenylephrine bolus
17(31%)
Atropine given
7 (13%)
Amount of Fluids used 746mls

The time from induction of spinal anaesthesia to delivery
was similar in both groups (range from 15-40 minutes)
as was the sensory level by cold touch before the start of
surgery as shown in table 2.
There was 35.2% incidence of at least one episode of
hypotension in the control group (Fixed dose group) and
18.6% in the intervention group (weight adjusted group).
This difference in the incidence of hypotension between
the two groups was found to be of borderline statistical
significance (p value of 0.051) as shown in table 3.

Intervention: weight adjusted dose
Percentage/Mean
5( 9%)
10(19%)
6 (11%)
712mls

P- Value
0.374
0.119
0.73
0.15

The test for differences in the two incidence rates the test
of whether the IRR=1 against that it is different from 1
was statistically significant, P=0.035. This was a coincidental finding however; as our study was not powered to
detect this difference.

Based on the lower proportion of hypotension in the
weight adjusted dose group compared to the fixed dose
group table 3 and the much lower incidence rate of hypotension as illustrated in table 4, there is good evidence for
the alternate hypothesis that a weight adjusted infusion
results in a lower incidence of hypotension compared to
The overall total person time minutes to hypotension was a fixed dose infusion.
1400 minutes, with 636 minutes for the control arm and
764 in the intervention arm. The incidence rate of hy- Figure 2 presents the survival distribution by the treatpotension in the fixed dose group was 3 per 100 person ment group when the event of interest is hypotension.
minutes 95% CI 1.9- 4.7 compared to 1.3 per 100 per- The Log rank test is not significant implying that the two
son minutes 95% CI: 0.7- 2.4 in the weight adjusted dose survival distributions are not different, P value of 0.06.
group. The rate ratio was 2.3 per 100 person minute the This may be due to the closeness of the curves in the first
patients in the control group had twice the risk of devel- 4 minutes. The curves however, are far from each other
oping hypotension compared to those in the intervention after 10 minutes. The intervention arm had a higher surgroup and a hazard ratio of 0.43, meaning that patients in vival probability compared to the control arm, implying
the intervention arm had 57% chance of protection from that the intervention arm had a reduced chance of developing hypotension after 10 minutes compared to the
hypotension.
control.
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Figure1. Flow diagram of patient distribution

Patients assessed for
Eligibility (108)

Excluded (0)

Randomized (108)

Weight
adjusted dose
infusion group
(54)

Fixed dose
infusion group
(54)

Lost to
follow up
(0)

Lost to
follow up(0)

Analyzed (108)

The rate of reactive hypertension was calculated for the
episodes that occurred over the total person time of observation. The control arm had an incidence rate of 1.6
95% CI: 0.8- 2.9 per 100 person minutes while the intervention arm had an incidence rate of hypertension of 0.9
95% CI: 0.4- 1.9 per 100 person minutes. The intervention arm had a reduced risk of hypertension but the test
for differences in the two incidence rates was not statistically significant, P=0.19.

giving an incidence rate ratio IRR of 0.74 95% CI: 0.0.37,
1.45. This implies that the weight adjusted dose arm had a
reduced risk of bradycardia but the test for differences in
the two incidence rates i.e. the test of whether the IRR=1
against that it is different from 1 was not statistically significant, P=0.349.

Phenylephrine infusion was stopped in 13 (12% ) of all
the patients, with 8 (15% ) and 5(9% ) in the control and
intervention arms respectively. The Chi Square test for
The fixed dose arm had an incidence rate of bradycardia difference in proportions between the two arms Control:
of 4.2 95% CI: 2.7, 6.2 per 100 person minutes while the 8 (15%); Intervention: 5 (9%) showed no evidence of asweight adjusted dose arm had an incidence rate of bra- sociation between the control and the intervention arms,
dycardia of 3.1 95% CI: 1.9, 4.8 per 100 person minutes Chi Square value=0.789 and P=0.374.
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Rescue Phenylephrine bolus was given to 27(25%) participants. Of this number, 17(31%) were from the control arm while 10(19%) were from the intervention arm.
There was no evidence of any association between bolus
and treatment, Chi Square value=2.435, P=0.119.
Similarly, atropine was given to 13(12%) of the participants. The proportions of those who received atropine
in the control and intervention arms were 6(11%) and
7(13%0 respectively. The Chi Square test for association
showed no evidence of association between the treatment and atropine, Chi Square value=0.111 and P=0.739.
There was no significant difference in the amount of intravenous fluids Ringer’s Lactate used between the two
groups p= 0.15

sion at a weight adjusted dose in the prevention of maternal hypotension following spinal anaesthesia. It is also
among the first studies investigating use of prophylactic
phenylephrine infusion to prevent maternal hypotension
in our patient population.
The principal finding of this study was that using a weight
adjusted dose of phenylephrine infusion resulted in a
lower proportion of hypotension compared to the use
of a fixed dose infusion, this difference was of borderline statistical significance. Prophylactic weight adjusted
dose infusion was also found to significantly reduce the
incidence rate of hypotension compared to when a fixed
dose infusion at 37.5µg/min was used Table 4.

This study was however not powered to detect a difDiscussion
To the best of our knowledge, this is the first study ever ference in the incidence rates. The lower rate of hypoinvestigating the use of prophylactic phenylephrine infu- tension in the weight adjusted dose group might be ex407
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plained by the pharmacokinetics of the drug, different
doses of drugs result in different plasma concentration
of the drug producing a range of therapeutic and some
undesirable responses. Following administration of a
drug, its plasma concentration rises to a maximum depending on; its volume of distribution and the dose that
has been administered19. Using a standard or a fixed dose
for all patients fails to account for the wide variation in
volumes of distribution20. When a drug is dosed based
on the patients’ weight the assumption made is that the
drug pharmacokinetic parameters increase as the body
size increases20 .This contrasts to using a fixed dose for
all patients whereby the assumption is that the pharmacokinetic parameters remain constant despite changes in
the body size20.
Phenylephrine is a synthetic, selective, sympathomimetic
agent alpha 1 agonist. It is usually administered intravenously, it has potent vasoconstrictor properties that occur almost immediately but only last for 15-20 minutes
hence it is necessary to administer it as an infusion21. It
is metabolized in the liver and excreted by the kidneys,
does not bind to plasma proteins and distributes widely
throughout the extracellular fluid. Hence administration
of phenylephrine in patients with varying weights suggests that weight adjusted phenylephrine dosing may be
an important consideration. In our study, we used the
lower limit of recommended weight adjusted dose of
phenylephrine at 0.5µg/kg/min, the reason for this was
to prevent accumulation and toxicity that may occur in
obese patients. In previous studies done on prophylactic
phenylephrine infusions the mean weight of the patients
studied was 65-70 kegs.
This contrasts to our study whereby the mean weight
was 85kgs, with a range of 60kgs – 110kgs. This might
explain why a higher incidence of hypotension was observed in our patients when the recommended fixed dose
regimen are used, 35.5% versus 30% reported by Allen
et al17. James T Miller et al conducted a retrospective
cohort study aimed at determining if the effects of vasopressin on blood pressure and other vasopressor requirement is related to body weight22.They demonstrated
that the efficacy of vasopressin reflected by a decrease in
other vasopressor requirement is significantly correlated
to its dose when adjusted for body weight22. Despite the
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fact that this is a different patient population and a different drug, and that this was a retrospective study these
two drugs are both vasopressors and the findings of this
study support weight adjusting the dose of vasopressors
to improve their efficacy.
The correct dosing approach can only be known if drug
pharmacokinetics are tested across a wide range of
weights: in our study the range was between 60-110kgs.
Another assumption made with weight based dosing is
that; there is a linear relationship between the clearance
of a drug and the bodyweight, and that the clearance of a
drug increases as the body weight increases20.The findings
in this trial suggests that in an effort to maintain maternal
systolic blood pressure as close to the baseline as possible
using weight adjusted dosing, prophylactic phenylephrine infusion might offer the advantage of reducing the
incidence rate of hypotension compared to using the infusion as a fixed dose for all patients regardless of their
weight. This could be explained by the fact that by weight
adjusting the dose, we avoid under dosing the drug in
some patients and increased toxicity in other patients.
In our study, we defined hypotension as a 20% decrease
in the systolic blood pressure from the baseline. Based
on a case series of prophylactic phenylephrine infusion
at 0.5µg/kg/min, we had postulated that only 3% of
patients in the weight adjusted group would develop hypotension for the entire duration of the study. The discrepancy between the postulated proportion in the intervention group and the results of the study was probably
due to a few methodological flaws in the anecdotal case
series: no protocol was followed in the administration of
fluids and the sample size was also very small. Furthermore there is a paucity of published well designed studies
that have used weight adjusted prophylactic phenylephrine infusion. The findings of this study are in keeping
with our hypothesis; the proportion of hypotension was
lower in the intervention arm compared to that in the
control arm Table 3.
The findings in the control group correspond closely
to the published proportion of hypotension of 23% by
Warwick Ngan Kee when he used a fixed dose of 100µg/
min16 and that by Terrence et al who found a proportion of 30% when a fixed dose infusion at 25µg/min was
used.17
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Reactive hypertension and bradycardia occur frequently
and are a major concern with the use of prophylactic
phenylephrine infusions. Although the differences in the
incidence rate ratio was not statistically significant, the
use of a weight adjusted infusion appeared to reduce the
risk of reactive hypertension, Table 5. This can again be
explained by the fact that by using the weight adjusted
dose especially in patients at the lower weight range we
avoided overexposing patients to a higher dose than necessary that would have resulted in reactive hypertension
and bradycardia. The proportions of reactive hypertension in this study closely compare to those reported by
Allen et al, whereby 25% of patients developed reactive
hypertension when a low dose infusion of 25µg/min
was used and 40% when a dose of 50µg/min was used17.
The proportion in the weight adjusted group was actually
much lower than that seen when the low dose infusion
was used at 25µg/min in an attempt to reduce the proportion of reactive hypertension.
Phenylephrine infusion is associated with an increase in
systemic vascular resistance and subsequently causes an
increase in the blood pressure and a baroreceptor mediated bradycardia. In an editorial Robert A Dyer suggested use of phenylephrine at low infusion rates to reduce
hypotension and avoid reactive hypertension and bradycardia associated with the use of phenylephrine infusion23. The proportion of bradycardia shown in Table 6
was much higher than the proportion observed by Allen
et al of 15% when a low dose of 25µg/min was used.
The reason for this is that, in their study bradycardia was
defined as a heart rate of less than 50 beats/min unlike in
our study where we defined it as a heart rate of less than
60 beats/min hence the conflicting results17.
Our study protocol was to discontinue the infusion when
baroreceptor mediated bradycardia occurred associated
with well-maintained blood pressure, rather than the
administration of an anticholinergic: hence the number of patients who received atropine was much lower
than those who developed bradycardia. According to this
work, the best way to reduce hypotension and avoid reactive hypertension and bradycardia is by using a prophylactic phenylephrine infusion at a dose adjusted according to
the patient’s weight, with supplemental boluses administered as necessary.
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There was no statistically significant difference between
the two groups in the amount of intravenous fluid Ringers lactate used Table 5. Similarly in this study there was
no difference in the number of physician interventions
between the control and the intervention arm in the entire duration of the study. According to the study protocol if the blood pressure dropped below 20% of the
baseline a phenylephrine 50µg bolus was given. As seen
in table 5 more patients in the control arm received phenylephrine bolus 17% versus only 7% in the intervention
group. This is due to the fact that the incidence rate of
hypotension was significantly higher in the control group
as compared to the intervention group Table 4. Similarly
the study protocol was to stop the phenylephrine infusion every time the patients’ blood pressure increased
above 20% of the baseline. Although the infusion was
stopped more frequently in the control group than in the
intervention group this difference was not statistically significant. This study was however not adequately powered
to detect these differences in the secondary outcomes.
No patient required conversion to general anaesthesia in
this study, and a majority of patients achieved a sensory
level of T6 before surgery began.
Although not reported, we did not see any adverse effects
on the fetus in our study as indicated by the Apgar score
that was part of the data collected. However it is well
known that any degree of decrease in maternal cardiac
output or blood pressure may have detrimental effect on
the fetus: by causing a reduction in placental blood flow
and subsequently a reduction in oxygen delivery to the fetus. This is even worse in the emergency situation where
fetal acidosis may already be present.
In such situations it is important that the anesthesiologist optimizes oxygen delivery to the fetus by maintaining maternal blood pressure and cardiac output as near
normal as possible. Hence based on the findings of this
study a prophylactic weight adjusted phenylephrine infusion will result in a lower drop in the maternal systolic
blood pressure and also less bradycardia and less reactive
hypertension.
Strengths of the study
After a rigorous literature review, it appears that this is
the first prospective randomized controlled study that has
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compared a prophylactic fixed dose infusion to a weight
adjusted dose infusion. Therefore, this study will add to
the body of literature and knowledge on prevention of
hypotension following spinal anesthesia given for caesarean section and probably form a basis for many other
studies in the future.
Limitations of the study
The study was conducted at a single centre and involved
a relatively small number of patients; this may impact on
the generalizability of the results of this study.
The calculation of the power of the current study was
based on a small number of anecdotal case series, and
not a large randomized clinical trial due to paucity of
published studies on prophylactic phenylephrine weight
adjusted dose infusion. The case series was retrospective,
no protocol was involved in the administration of fluids and vasopressors and the analysis was not rigorous
enough. This probably explains discrepancy between the
postulated proportion of hypotension and the findings
of the study
Conclusion
On the basis of the results of this study, patients in the
weight adjusted dose group had a lower incidence of hypotension compared to those in the fixed dose group.
This difference was of borderline statistical significance.
The difference in heart rate change (bradycardia) between
the two groups and reactive hypertension was not statistically significant. Therefore, we conclude that weight adjusting the dose of prophylactic phenylephrine infusion
at 0.5µg/kg/min results in a lower incidence of hypotension, slightly lower incidence of reactive hypertension
and bradycardia than administering it at a fixed dose of
37.5µg/min to all patients, regardless of their weight.
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